Abstracts tagged "infection and opportunistic infections"

Abstract Number: 896 • 2015 ACR/ARHP Annual Meeting
Herpes Zoster and the Short Term Risk for Ischemic Stroke in Patients with Autoimmune Diseases
Leonard H. Calabrese¹, Fenglong Xie², Huifeng Yun³, Kevin L. Winthrop⁴, John Baddley⁵, Cassandra Calabrese⁶ and Jeffrey R. Curtis⁷, ¹Rheumatic & Immunologic Dis, Cleveland Clinic Foundation, Cleveland, OH, ²Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, ³Epidemiology, University of Alabama at Birmingham, Birmingham, AL, ⁴Oregon Health and Science University, Portland, OR, ⁵Infectious Diseases, University of Alabama, Birmingham, AL, ⁶Cleveland Clinic Foundation, Cleveland, OH, ⁷University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Herpes zoster (HZ) is an opportunistic infection caused by Varicella Zoster Virus (VZV); HZ is observed with increasing frequency in patients on immunosuppressive therapies. HZ is not…
Abstract Number: 2040 • 2014 ACR/ARHP Annual Meeting
Opportunistic Infections in Patients Treated with Biologic Drug Therapy
Laura Encinas¹, Maria Haye Salinas¹, Veronica Saurit¹, Alejandro J. Alvarellos², Francisco Caeiro¹, Cristina Battagliotti³, Ida Elena Exeni⁴, Carla Gobbi⁵, Bernardo Pons-Estel⁶, Ingrid Strusberg⁷, Sergio Paira⁸, Eduardo Mussano⁹, Maria Apaz¹⁰, Ana Quinteros¹¹, Ana Capuccio¹², Mercedes De La Sota¹³, Maria Larroude¹⁴, Amelia Granel¹⁵, Oscar Rillo¹⁶, Enrique Soriano¹⁷, Gustavo Citera¹⁸, Diana Dubinsky¹⁹, Mari Delgado²⁰, Analia Alvarez²¹, Graciela Gómez²², Gustavo Casado²³, Santiago Aguero²⁴, Monica Sacnum²⁰, Mercedes Garcia²⁰, Sidney Soares de Souza²⁵, Edson Javier Velozo²⁶, C Paruolo²⁰, Monica Patricia Diaz²⁷, Emilia Cavillion²⁸, Juan C. Barreira²⁹, Gimena Gómez³⁰ and E. Scheines³¹, ¹Reumatología, Hospital Privado de Córdoba, Córdoba, Argentina, ²Reumatología, Hospital Privado Córdoba, Córdoba, Argentina, ³Hospital de Niños Dr Orlando Alasia, Santa Fé, Argentina, ⁴Sanatorio Parque, Cordoba, Argentina, ⁵Hospital Còrdoba, Còrdoba, Argentina, ⁶Sanatorio Parque, Rosario, Argentina, ⁷Instituto Reumatológico Strusberg, Cordoba, Argentina, ⁸Section of Rheumatology, Hospital Jose Maria Cullen, Santa Fe, Argentina, ⁹Hospital Nacional De Clinicas, Mariquita Sanchez 2304, Buenos Aires, Argentina, ¹⁰Pediatric Rheumatology, Hospital de niños de cordoba, córdoba, Argentina, Argentina, ¹¹Centro Integral de Reumatología, Tucumán, Argentina, ¹²Rheumatology, Hospital cesar Milstein, Buenos Aires, Argentina, ¹³Consultorio, Bahia Blanca, Argentina, ¹⁴Consultorio, Buenos Aires, Argentina, ¹⁵Rheumatology, Hospital San Roque de Gonnet, La Plata, La Plata, Argentina, ¹⁶Rheumatology, Hospital Sirio Libanes, Buenos Aires, Argentina, ¹⁷Hospital Italiano, Buenos Aires, Argentina, ¹⁸Universidad de Buenos Aires, Buenos Aires, Argentina, ¹⁹Rheumatology, Hospital de Clinicas, Jose de San Martin, Capital Federal, Argentina, ²⁰consultorio, Buenos Aires, Argentina, ²¹Cemic, Buenos Aires, Argentina, ²²Diaz Colodrero 2537 8° A, Insituto de Investigaciones Medicas de la UBA, Capital Federal, Argentina, ²³Hospital Militar Central, Buenos Aires, Argentina, ²⁴Pasaje Sanchez Gardel 148, Sanatorio Pasteur, Catamarca, Argentina, ²⁵REUMAR, Buenos Aires, Argentina, ²⁶25 DE MAYO 255 -LIBERTADOR SAN, Sanatorio Adventista Del Plata, Entre Rios, Argentina, ²⁷Espana 327, consultorio, Bariloche, Argentina, ²⁸Consultorio, Cordoba, Argentina, ²⁹Rheumatology, British Hospital, Buenos Aires, Argentina, ³⁰Hospital Argerich, Buenos Aires, Argentina, ³¹Rheumatology, Hospital Manuel Rocca, Ciudad Autonoma de Buenos Aires, Argentina
Background/Purpose Biological drug therapy is frequently used to treat autoimmune diseases.These drugs have an increased risk of infections, among them opportunistic infections.To evaluate the frequency…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].